STZ

— Fundamental Stock Analysis and Report Card

Consumer Defensive : Beverages - Alcoholic

Located in Rochester, NY, US. Constellation Brands, Inc., together with its subsidiaries, produces, imports, markets, and sells beer, wine, and spirits in the United States, Canada, Mexico, New Zealand, and Italy. The company offers beer under the Corona Extra, Corona Familiar, Corona Hard Seltzer, Corona Light, Corona Non-Alcoholic, Corona Premier, Corona Refresca, Modelo Especial, Modelo Chelada, Modelo Negra, Modelo Oro, Victoria, Vicky Chamoy, and Pacifico brands. It also offers wine under the Cook’s California Champagne, Kim Crawford, Meiomi, Mount Veeder, Ruffino, SIMI, My Favorite Neighbor, Robert Mondavi Winery, Schrader, and The Prisoner Wine Company brands; and spirits under the Casa Noble, Copper & Kings, High West, Mi CAMPO, Nelson’s Green Brier, and SVEDKA brands. The company provides its products to wholesale distributors, retailers, on-premise locations, and state alcohol beverage control agencies. Constellation Brands, Inc. was founded in 1945 and is based in Rochester, New York.

Growth

Revenue, earnings and profitability.

Strong revenue growth and earnings can attract investors, driving the stock price up. Profitability indicates the company's efficiency and sustainability, which impacts investor confidence. Poor performance in these areas can lead to a decrease in stock price.

Revenue History

Earnings History

Margins

Gross Margin TTM
52.62%
EBITDA Margin TTM
36.53%
Net Margin TTM
20.14%
Earnings Per Share TTM
10.60
Statements

Income & Cash Flow analysis.

An income statement shows what a company earned and spent over a period — revenue at the top, costs and expenses in between, and net income at the bottom. A cash flow statement tracks the actual cash moving in and out, across operations, investing, and financing. Read together, they show whether reported earnings are backed by real cash.

Constellation Brands, Inc.
Select Period:
Q1 2027
Total ($)
Q1 2027
Margin (%)
Revenue
2.4b
-82.0m
-3.3%
Gross Income
1.3b
+43.9m
+3.4%
54%
+3.5pp
+6.9%
EBITDA
971.7m
+154.2m
+18.9%
40%
+7.4pp
+22.9%
Operating Income
845.3m
+47.0m
+5.9%
35%
+3.0pp
+9.5%
Net Income
653.8m
+137.7m
+26.7%
27%
+6.4pp
+31.0%
Earnings Per Share
3.80
+0.9
+31.0%
Operating Cash Flow
661.8m
+24.6m
+3.9%
27%
+1.9pp
+7.4%
Free Cash Flow
484.6m
+40.2m
+9.0%
20%
+2.2pp
+12.7%
Research & Development
n/a
n/a
n/a
n/a
n/a
n/a
Recommendations

What are the analysts saying?

Analyst Consensus aggregates Wall Street recommendations into buy/hold/sell counts, while the Fundamental Scorecard grades the company on six financial ratios (P/B, P/E, D/E, ROA, ROE, DCF) plus an overall score. The two measure different things and can point in different directions.

Analyst Consensus
Fundamental Scorecard
Recent Upgrades & Downgrades